NO156010C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, vannopploeselige salter av (+)-katechin. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, vannopploeselige salter av (+)-katechin.

Info

Publication number
NO156010C
NO156010C NO802563A NO802563A NO156010C NO 156010 C NO156010 C NO 156010C NO 802563 A NO802563 A NO 802563A NO 802563 A NO802563 A NO 802563A NO 156010 C NO156010 C NO 156010C
Authority
NO
Norway
Prior art keywords
catechin
preparation
water soluble
therapeutically active
soluble salts
Prior art date
Application number
NO802563A
Other languages
English (en)
Other versions
NO802563L (no
NO156010B (no
Inventor
Paul J Niebes
Andreas B Vincze
Joseph Roba
Georges E Lambelin
Daniel M Matagne
Etienne P Hanon
Michel R Franz
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of NO802563L publication Critical patent/NO802563L/no
Publication of NO156010B publication Critical patent/NO156010B/no
Publication of NO156010C publication Critical patent/NO156010C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
NO802563A 1979-08-30 1980-08-29 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, vannopploeselige salter av (+)-katechin. NO156010C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/071,076 US4285964A (en) 1979-08-30 1979-08-30 Salts of (+)-catechine, their preparation and use, and compositions containing these salts

Publications (3)

Publication Number Publication Date
NO802563L NO802563L (no) 1981-03-02
NO156010B NO156010B (no) 1987-03-30
NO156010C true NO156010C (no) 1987-07-08

Family

ID=22099096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802563A NO156010C (no) 1979-08-30 1980-08-29 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, vannopploeselige salter av (+)-katechin.

Country Status (18)

Country Link
US (1) US4285964A (no)
JP (2) JPS5923313B2 (no)
AT (1) AT372381B (no)
BE (1) BE884743A (no)
CA (1) CA1172259A (no)
CH (1) CH646412A5 (no)
DE (1) DE3031710C2 (no)
DK (1) DK153948C (no)
ES (1) ES494668A0 (no)
FI (1) FI72724C (no)
FR (1) FR2464262A1 (no)
GB (1) GB2057437B (no)
GR (1) GR69849B (no)
IE (1) IE50231B1 (no)
IT (1) IT1193979B (no)
NL (1) NL183080C (no)
NO (1) NO156010C (no)
SE (1) SE448455B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507314A (en) * 1983-07-20 1985-03-26 Midit, Societe Fiduciaire Drug for treating affections provoked by a too high histamine level, of the gastroduodenal mucosa and allergic affections
JPH0415053Y2 (no) * 1985-04-19 1992-04-06
WO1987006128A1 (en) * 1986-04-07 1987-10-22 Clemetson Ab Charles Catechin coated ascorbic acid and method
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH0662408B2 (ja) * 1987-10-01 1994-08-17 太陽化学株式会社 抗う蝕及び抗歯周病組成物
JPH0672091B2 (ja) * 1988-04-13 1994-09-14 太陽化学株式会社 抗う蝕組成物
US5090785A (en) * 1990-07-31 1992-02-25 Stamp John R Multi-compartment container
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
GB2306321A (en) * 1995-10-24 1997-05-07 Anne Child The use of (+)-catechin in the treatment or prophylaxis of connective tissue disorders
GB9700912D0 (en) 1997-01-17 1997-03-05 Chiroscience Ltd Resolution
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US6358539B1 (en) 1999-08-20 2002-03-19 Howard Murad Pharmaceutical compositions for reducing the appearance of cellulite
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
WO2006124033A2 (en) * 2005-05-17 2006-11-23 Mitsui Norin Co., Ltd Compositions and methods for reduction of cutaneous photoageing
WO2011014563A1 (en) 2009-07-29 2011-02-03 Vatrix Medical, Inc. Tissue stabilization for heart failure
WO2011104667A1 (en) * 2010-02-25 2011-09-01 Anthem Biosciences Private Limited Basic aminoacid salts of polyphenols
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
EP2709711B8 (en) 2011-05-18 2017-03-22 Vatrix Medical, Inc. Coated balloons for blood vessel stabilization
BE1023772B9 (fr) 2013-05-17 2017-08-02 Valore Composition a base d'un complexe de (+)-catechine et d'acide amine pour le traitement et la prevention du cancer
BE1022579A9 (fr) * 2014-11-10 2016-10-06 Valore Composition antimétastatique comprenant au moins un composé de type flavanol
TWI761672B (zh) 2018-04-23 2022-04-21 日商阿爾卑斯藥品工業股份有限公司 O-醣苷基類黃酮之組成物
US10617705B1 (en) 2019-01-24 2020-04-14 Alps Pharmaceutical Ind. Co., Ltd. Isoquercitrin compositions
US10918654B1 (en) 2019-09-23 2021-02-16 Alps Pharmaceutical Ind. Co., Ltd. Rutin compositions
US11110109B2 (en) 2019-10-22 2021-09-07 Alps Pharmaceutical Ind. Co., Ltd. Water soluble O-glycosyl flavonoid compositions and methods for preparing same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270003A (en) * 1964-08-07 1966-08-30 Rayonier Inc Iron complexed sulfonated polyflavonoids and their preparation
FR2128207B1 (no) * 1971-03-11 1974-08-02 Zyma Sa
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01

Also Published As

Publication number Publication date
FR2464262B1 (no) 1983-07-08
NL8004873A (nl) 1981-03-03
FI72724B (fi) 1987-03-31
SE8005890L (sv) 1981-03-01
CH646412A5 (fr) 1984-11-30
ES8106513A1 (es) 1981-08-16
NL183080C (nl) 1988-07-18
AT372381B (de) 1983-09-26
SE448455B (sv) 1987-02-23
DE3031710A1 (de) 1981-03-12
JPS5923313B2 (ja) 1984-06-01
FI802652A (fi) 1981-03-01
BE884743A (fr) 1980-12-01
ES494668A0 (es) 1981-08-16
FR2464262A1 (fr) 1981-03-06
IT8024310A0 (it) 1980-08-27
IE50231B1 (en) 1986-03-05
NO802563L (no) 1981-03-02
DK358980A (da) 1981-03-01
GR69849B (no) 1982-07-19
DK153948C (da) 1989-02-13
FI72724C (fi) 1987-07-10
GB2057437B (en) 1984-08-30
IT1193979B (it) 1988-08-31
IE801823L (en) 1981-02-28
US4285964A (en) 1981-08-25
JPS5655386A (en) 1981-05-15
JPS59144779A (ja) 1984-08-18
ATA432080A (de) 1983-02-15
DE3031710C2 (de) 1987-03-12
DK153948B (da) 1988-09-26
GB2057437A (en) 1981-04-01
CA1172259A (en) 1984-08-07
JPS5946947B2 (ja) 1984-11-15
NO156010B (no) 1987-03-30

Similar Documents

Publication Publication Date Title
NO156010C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, vannopploeselige salter av (+)-katechin.
NO154964C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive piperidinderivater.
NO154521C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater.
NO153927C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-substituerte 4-amino-3-kinolinsyrederivater.
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO159531C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO823520L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive carbohydrater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO155289C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater.
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO154396C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater.